Despite this heterogeneity, however, the loss of ASCL1 still significantly delays tumor progression and resulted in a significant increase in survival for mice with Ascl1CKO tumors over those mice with Ascl1WT tumors, illustrating an important role for ASCL1 in controlling the rate of glioma proliferation in vivo. Here, ASCL1 is linked to central nervous system cancer.